The product-led growth framework we install for every client for healthcare and life sciences in the DACH region

This edition of the Growth Broker playbook is written for commercial leaders at healthtech, medtech, and life-sciences companies operating in the DACH region. In this market, DACH buyers reward rigour, documentation, and long-cycle trust — not urgency-led campaigns, so the way you install product-led growth has to be shaped to that reality from day one.

We have installed product-led growth inside more than fifty companies. This is the framework we reach for every time. Product-led growth is using product usage — not a rep — as the primary lead source, and the framework exists to keep that definition honest under real conditions.

Part one, diagnosis. Before you touch the model, name the constraint: finance, demand, access, or conversion. Product-led growth applied to the wrong constraint is theatre.

Part two, target. Narrow to one industry, one role, one trigger. Every extra dimension halves conversion.

Inside healthcare and life sciences, the binding constraint is almost always regulated-sale cycle length, not intent, and in the DACH region it is compounded by the fact that trust-building cycle length, not intent is what actually gates growth. Product-led growth is only useful here when it is pointed at both constraints at once.

Part three, offer. What is the buyer's next step, and what makes it obvious? The offer, not the copy, is what carries.

Part four, engine. Tools, sequences, data. Buy the minimum you can operate; every extra tool is a future dependency.

Part five, operating rhythm. Monday plan, Friday review, weekly self-serve activation to paid conversion. Nothing about the model is left to memory.

Parts six and seven, learning and allocation. What did we learn last week; where does next week's dollar go. Once those two loops are live, product-led growth compounds and the framework stops being visible.

Concretely for healthcare and life sciences in the DACH region: the healthcare teams that install this get past procurement instead of dying in it, and one properly-run DACH account survives leadership changes and compounds for years. That is the reason it is worth installing product-led growth deliberately for this market rather than importing a playbook designed for somewhere else.